Exploitation of immunogenicity of Cep 55 to enhance efficacy of therapy for triple-negative breast cancer (2024)
- Grant type:
- National Breast Cancer Foundation Investigator Initiated Research Scheme
- Researchers:
-
-
Honorary Professor
Mater Research Institute-UQFaculty of MedicineHonorary Professor
Mater Research Institute-UQFaculty of Medicine
-
- Funded by:
- National Breast Cancer Foundation
